|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Risks and benefits of copper in light new insights of copper homeostasis 显示文摘 | De Romana DL Olivares M Uauy R | 2011 | J Trace Elem Med Biol2011，25，1： | 1 |
| 2 | A geomechanical classification for slopes:slope mass rating显示文摘 | ROMANA M R | 1993 | Comprehensive Rock Engineering1993，3，： | 1 |
| 3 | Effect of telmisaartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease 显示文摘 | Romana R Vladimir T Miroslav M | 2005 | Blood Pressure Monitoring2005，10，4： | 1 |
| 4 | t( 12:21 ) :A new recurrent translocation in acute lympUoblastic leukemia 显示文摘 | Romana SP Le Coniat M Berger R | 1994 | Genes Chro- mosomes Caner1994，9，3： | 1 |
| 5 | Debriefing after a crisis显示文摘 | Hanna D R Romana M | 2007 | Nurs Manag2007，38，8： | 1 |
| 6 | A geomechanical classification for slope mass rating显示文摘 | ROMANA M R | 1993 | Comprehensive Rock Mechanics1993，，3： | 1 |
| 7 | Echo—color Doppler in thyroid disease显示文摘 | Lagalla R Romana M | | 0，，： | 1 |
| 8 | A geomechanical classification for slopes: slope mass rating显示文摘 | ROMANA M R | 1993 | Comprehensive Rock Engineering1993，，57： | 1 |
| 9 | A Geomechanical Classification for Slope Mass Rating 显示文摘 | ROMANA M R | 1993 | Comprehensive Rock Mechanics1993，，3： | 1 |
| 10 | Risks and benefits of copper in light of new insights of copper homeostasis 显示文摘 | de Romana D L Olivares M Uauy R | 2011 | J Trace Elem Med Biol2011，25，1： | 1 |
| 11 | Risks and benefits ofcopper in light of new insights of copper homeostasis显示文摘 | de Romana DL Olivares M Uauy R | 2011 | J TraceElem Med Biol2011，25，1： | 1 |
| 12 | t (12;21):a new recurrent translocation in acute lymphoblastic leukemia显示文摘 | Romana SP Le Coniat M Berger R | 1994 | Genes Chromosomes&Cancer1994，9，3： | 1 |
| 13 | A geomechanical classification for slope mass rating显示文摘 | ROMANA M R | 1993 | Comprehensive Rock Mechanics1993，，3： | 1 |
| 14 | Recovery of pure B-phycoerythrin from the microalga Porphyridium cruentum显示文摘 | R Bermejo Romana J M Alva rez-Pez b F G Acien Ferna ndez c | 2002 | Journal of Biotechnology2002，93，： | 1 |
| 15 | Echo-color Doppler in thyroid disease显示文摘 | Lagalla R Caruso G Romana M | 1993 | Radiol Med Torino1993，85，5： | 1 |
| 16 | Effect of telmisaartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease显示文摘 | Romana R Vladimir T Miroslav M | 2005 | Blood Pres Mon2005，10，4： | 1 |
| 17 | A geomechanical classification for slopes : slope mass rating显示文摘 | ROMANA M R | 1993 | Comprehensive Rock Engineering1993，，3： | 1 |
| 18 | B cells in pancreatic cancer stroma显示文摘Pancreatic cancer is a disease with high unmet clinical need.Pancreatic cancer is also characterised by an intense fibrotic stroma,which harbours many immune cells.Studies in both human and animal models have demonstrated that the immune system plays a crucial role in modulating tumour onset and progression.In human pancreatic ductal adenocarcinoma,high B-cell infiltration correlates with better patient survival.Hence,B cells have received recent interest in pancreatic cancer as potential therapeutic targets.However,the data on the role of B cells in murine models is unclear as it is dependent on the pancreatic cancer model used to study.Nevertheless,it appears that B cells do organise along with other immune cells such as a network of follicular dendritic cells(DCs),surrounded by T cells and DCs to form tertiary lymphoid structures(TLS).TLS are increasingly recognised as sites for antigen presentation,T-cell activation,Bcell maturation and differentiation in plasma cells.In this review we dissect the role of B cells and provide directions for future studies to harness the role of B cells in treatment of human pancreatic cancer. | Francesca Romana Delvecchio Michelle R Goulart Rachel Elizabeth Ann Fincham Michele Bombadieri Hemant M Kocher | 2022 | World Journal of Gastroenterology2022，28，11： | 0 |
| 19 | Observatory science with eXTP显示文摘In this White Paper we present the potential of the enhanced X-ray Timing and Polarimetry(eXTP) mission for studies related to Observatory Science targets. These include flaring stars, supernova remnants, accreting white dwarfs, low and high mass X-ray binaries, radio quiet and radio loud active galactic nuclei, tidal disruption events, and gamma-ray bursts. eXTP will be excellently suited to study one common aspect of these objects: their often transient nature. Developed by an international Consortium led by the Institute of High Energy Physics of the Chinese Academy of Science, the eXTP mission is expected to be launched in the mid 2020s. | Jean J.M.in 't Zand Enrico Bozzo JinLu Qu Xiang-Dong Li Lorenzo Amati Yang Chen Immacolata Donnarumma Victor Doroshenko Stephen A.Drake Margarita Hernanz Peter A.Jenke Thomas J.Maccarone Simin Mahmoodifar Domitilla de Martino Alessandra De Rosa Elena M.Rossi Antonia Rowlinson Gloria Sala Giulia Stratta Thomas M.Tauris Joern Wilms XueFeng Wu Ping Zhou Iván Agudo Diego Altamirano Jean-Luc Atteia Nils A.andersson M.Cristina Baglio David R.Ballantyne Altan Baykal Ehud Behar Tomaso Belloni Sudip Bhattacharyya Stefano Bianchi Anna Bilous Pere Blay Joao Braga Sφren Brandt Edward F.Brown Niccolo Bucciantini Luciano Burderi Edward M.Cackett Riccardo Campana Sergio Campana Piergiorgio Casella Yuri Cavecchi Frank Chambers Liang Chen Yu-Peng Chen Jér?me Chenevez Maria Chernyakova ChiChuan Jin Riccardo Ciolfi Elisa Costantini Andrew Cumming Antonino D'Aì Zi-Gao Dai Filippo D'Ammando Massimiliano De Pasquale Nathalie Degenaar Melania Del Santo Valerio D'Elia Tiziana Di Salvo Gerry Doyle Maurizio Falanga XiLong Fan Robert D.Ferdman Marco Feroci Federico Fraschetti Duncan K.Galloway Angelo F.Gambino Poshak Gandhi MingYu Ge Bruce Gendre Ramandeep Gill Diego G?tz Christian Gouiffès Paola Grandi Jonathan Granot Manuel Güdel Alexander Heger Craig O.Heinke Jeroen Homan Rosario Iaria Kazushi Iwasawa Luca Izzo Long Ji Peter G.Jonker Jordi José Jelle S.Kaastra Emrah Kalemci Oleg Kargaltsev Nobuyuki Kawai Laurens Keek Stefanie Komossa Ingo Kreykenbohm Lucien Kuiper Devaky Kunneriath Gang Li En-Wei Liang Manuel Linares Francesco Longo FangJun Lu Alexander A.Lutovinov Denys Malyshev Julien Malzac Antonios Manousakis Ian McHardy Missagh Mehdipour YunPeng Men Mariano Méndez Roberto P.Mignani Romana Mikusincova M.Coleman Miller Giovanni Miniutti Christian Motch Joonas Nättilä Emanuele Nardini Torsten Neubert Paul T.O'Brien Mauro Orlandini Julian P.Osborne Luigi Pacciani Stéphane Paltani Maurizio Paolillo Iossif E.Papadakis Biswajit Paul Alberto Pellizzoni Uria Peretz Miguel A.Pérez Torres Emanuele Perinati Chanda Prescod-Weinstein Pablo Reig Alessandro Riggio Jerome Rodriguez Pablo Rodríguez-Gil Patrizia Romano Agata Rózańska Takanori Sakamoto Tuomo Salmi Ruben Salvaterra andrea Sanna andrea Santangelo Tuomas Savolainen Stéphane Schanne Hendrik Schatz LiJing Shao andy Shearer Steven N.Shore Ben W.Stappers Tod E.Strohmayer Valery F.Suleimanov Jirí Svoboda F.-K.Thielemann Francesco Tombesi Diego F.Torres Eleonora Torresi Sara Turriziani andrea Vacchi Stefano Vercellone Jacco Vink Jian-Min Wang JunFeng Wang Anna L.Watts ShanShan Weng Nevin N.Weinberg Peter J.Wheatley Rudy Wijnands Tyrone E.Woods Stan E.Woosley ShaoLin Xiong YuPeng Xu Zhen Yan George Younes WenFei Yu Feng Yuan Luca Zampieri Silvia Zane andrzej A.Zdziarski Shuang-Nan Zhang Shu Zhang Shuo Zhang Xiao Zhang Michael Zingale | 2019 | Science China(Physics,Mechanics & Astronomy)2019，62，2： | 0 |
| 20 | Natural killer cells in pancreatic cancer stroma显示文摘Pancreatic cancer remains one of medicine’s largest areas of unmet need.With five-year survival rates of<8%,little improvement has been made in the last 50 years.Typically presenting with advance stage disease,treatment options are limited.To date,surgery remains the only potentially curative option,however,with such late disease presentation,the majority of patients are unresectable.Thus,new therapeutic options and a greater understanding of the complex stromal interactions within the tumour microenvironment are sorely needed to revise the dismal outlook for pancreatic cancer patients.Natural killer(NK)cells are crucial effector units in cancer immunosurveillance.Often used as a prognostic biomarker in a range of malignancies,NK cells have received much attention as an attractive target for immunotherapies,both as cell therapy and as a pharmaceutical target.Despite this interest,the role of NK cells in pancreatic cancer remains poorly defined.Nevertheless,increasing evidence of the importance of NK cells in this dismal prognosis disease is beginning to come to light.Here,we review the role of NK cells in pancreatic cancer,examine the complex interactions of these crucial effector units within pancreatic cancer stroma and shed light on the increasingly attractive use of NK cells as therapy. | Rachel Elizabeth Ann Fincham Francesca Romana Delvecchio Michelle R Goulart Joe Poe Sheng Yeong Hemant M Kocher | 2021 | World Journal of Gastroenterology2021，27，24： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员